GH Research (GHRS) Long-Term Investments (2021 - 2025)
GH Research's (GHRS) quarterly Long-Term Investments came in at $34.5 million in Q4 2025, up 3.47% year-on-year from $33.3 million in Q4 2024, and down 11.31% quarter-over-quarter from $38.9 million in Q3 2025.
GH Research (GHRS) Long-Term Investments (2021 - 2025) Analysis & Trends
GH Research's Long-Term Investments history runs 5 years deep, the most recent figure standing at $34.5 million for Q4 2025.
- On a quarterly basis, Long-Term Investments rose 3.47% year-over-year to $34.5 million in Q4 2025; TTM through Dec 2025 was $34.5 million, a 3.47% increase from a year earlier, with the FY2025 full-year figure at $34.5 million, up 3.47% from the prior year.
- Long-Term Investments slipped to $34.5 million in Q4 2025 per GHRS's latest filing, from $38.9 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $122.1 million in Q4 2021 and bottomed at $33.3 million in Q4 2024.
- The 5-year median for Long-Term Investments is $54.7 million (2024), against an average of $58.8 million.
- Across the five-year window, Long-Term Investments sank 45.54% in 2024 and increased 3.47% in 2025, its largest moves.
- Year by year, Long-Term Investments stood at $122.1 million in 2021, then declined by 29.78% to $85.7 million in 2022, then dropped by 28.68% to $61.1 million in 2023, then plunged by 45.54% to $33.3 million in 2024, then advanced by 3.47% to $34.5 million in 2025.
- Per Business Quant, the three latest GHRS Long-Term Investments figures stand at $34.5 million (Q4 2025), $38.9 million (Q3 2025), and $37.7 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | GH Research | 1.69 Bn | 1.69 Bn | - | 34.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.46 Mn |
| Sep 30, 2025 | 38.85 Mn |
| Jun 30, 2025 | 37.66 Mn |
| Mar 31, 2025 | 33.84 Mn |
| Dec 31, 2024 | 33.30 Mn |
| Sep 30, 2024 | 43.81 Mn |
| Jun 30, 2024 | 53.17 Mn |
| Mar 31, 2024 | 56.13 Mn |
| Dec 31, 2023 | 61.14 Mn |
| Sep 30, 2023 | 67.45 Mn |
| Jun 30, 2023 | 72.70 Mn |
| Mar 31, 2023 | 83.32 Mn |
| Dec 31, 2022 | 85.72 Mn |
| Dec 31, 2021 | 122.08 Mn |